Successful treatment of glucagonoma-related necrolytic migratory erythema with dacarbazine (Q70166498)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3029193%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Successful treatment of glucagonoma-related necrolytic migratory erythema with dacarbazine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3029193%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference

T L van der Loos

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3029193%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

E R Lambrecht

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3029193%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

J C Lambers

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3029193%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

language of work or name

English

0 references

publication date

1 February 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3029193%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American Academy of Dermatology

9 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3029193%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3029193%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

2 Pt 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3029193%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

468-472

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3029193%20AND%20SRC:MED&resulttype=core&format=json

CUTANEOUS MANIFESTATIONS OF INTERNAL MALIGNANT TUMORS

9 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970063-2

7 January 2021

A glucagon-secreting alpha-cell carcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970063-2

7 January 2021

Necrolytic Migratory Erythema Without Glucagonoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970063-2

7 January 2021

Glucagonoma without cutaneous manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970063-2

7 January 2021

The glucagonoma syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970063-2

7 January 2021

Glucagonoma Syndrome: Case Report and Literature Review

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970063-2

7 January 2021

A glucagonoma syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970063-2

7 January 2021

Necrolytic migratory erythema. Distinctive dermatosis of the glucagonoma syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970063-2

7 January 2021

Glucagonoma syndrome. Report of two cases and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970063-2

7 January 2021

Amino Acid Deficiency and the Skin Rash Associated with Glucagonoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970063-2

7 January 2021

A dermatosis specifically associated with a tumour of pancreatic alpha cells

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970063-2

7 January 2021

Glucagonoma syndrome. A clinicopathologic, immunocytochemical, and ultrastructural study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970063-2

7 January 2021

Effect of somatostatin in necrolytic migratory erythema of glucagonoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970063-2

7 January 2021

Functional studies in patients with the glucagonoma syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970063-2

7 January 2021

Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970063-2

7 January 2021

Streptozocin Alone Compared with Streptozocin plus Fluorouracil in the Treatment of Advanced Islet-Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970063-2

7 January 2021

Malignant Somatostatinoma: Clinical Features and Metabolic Studies*

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970063-2

7 January 2021

The glucagonoma syndrome and its management

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970063-2

7 January 2021

Dimethyltriazenoimidazole Carboxamide Therapy of Malignant Glucagonoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970063-2

7 January 2021

Malignant Glucagonoma Syndrome: Response to Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970063-2

7 January 2021

Dimethyltriazenoimidazole carboxamide therapy of islet cell carcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970063-2

7 January 2021

Therapy of malignant APUD cell tumors: Effectiveness of DTIC

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970063-2

7 January 2021

Unsuccessful DTIC treatment of a Patient with Glucagonoma Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970063-2

7 January 2021

10.1016/S0190-9622(87)70063-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3029193%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference